uniQure to Participate in Multiple Upcoming Industry Conferences
~ Company to Host Investor Call on Friday, February 8, 2019 at 8:30 a.m. ET to Discuss Updated Clinical Data […]
Nasdaq Reports Fourth Quarter and Full Year 2018 Results; Delivers Strong Revenue Growth in 2018
2018 net revenues1 were $2,526 million, an increase of 5% compared to 2017, resulting from 8% organic growth partially offset […]
Nasdaq Announces Quarterly Dividend of $0.44 Per Share
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) — The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a […]
Trevena Announces $10 Million Registered Direct Offering of Common Stock
CHESTERBROOK, Pa., Jan. 30, 2019 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN) (the “Company”) today announced that it entered into […]
Axsome Therapeutics Initiates Phase 2 Trial of AXS-12 in Narcolepsy
Topline results anticipated in 2Q 2019 NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a […]
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Research and Development
REHOVOT, Israel, Jan. 30, 2019 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, announced […]
Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis
MIST-1 study met primary endpoint First-in-class fixed combination mydriatic agent demonstrated robust efficacy, high tolerability; Study further validates OpteJet™ platform […]
TSX News -
goeasy Ltd. Announces Timing of Fourth Quarter 2018 Conference Call and Webcast
MISSISSAUGA, Ontario, Jan. 30, 2019 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX:GSY), (“goeasy” or the “Company”), a leading full-service provider of […]
Osisko Metals Intersects 14.87% Zinc+Lead Over 12.74 Metres at Pine Point and Grants Stock Options
MONTREAL, Jan. 30, 2019 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V: OM; FRANKFURT: OB51) is […]
Emerald Health Therapeutics Announces Discharge of Litigation
VANCOUVER, British Columbia, Jan. 30, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) announced today that its […]
